feed,title,long_url,short_url
Benzinga,BioXcel Therapeutics Starts Testing BXCL501 In Mid-Stage Delirium-Related Agitation Study,https://benzinga.com/general/biotech/21/02/19856815/bioxcel-therapeutics-starts-testing-bxcl501-in-mid-stage-delirium-related-agitation-study,
